Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lily of the Desert is a vertically integrated producer of organic aloe vera products, serving the health and wellness industry since 1971. The company manages the entire production process, from growing organic aloe vera on its own farms to processing and bottling in its own facilities. Their product portfolio includes dietary supplements, juices, and topical gels designed to support digestive health, immune function, and skin care. A key innovation is their patented Aloesorb technology, which concentrates high-molecular-weight aloe polysaccharides to improve the absorption of nutrients. Lily of the Desert distinguishes itself through a commitment to scientific research, having conducted numerous clinical studies to validate the efficacy and safety of its aloe-based formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lily of the Desert.